RVL Pharmaceuticals plc (RVLP) Reports In-Line Q1 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to RVL Pharmaceuticals plc (RVLP) Reports In-Line Q1 EPS

RVL Pharmaceuticals plc Reports First Quarter 2023 Financial Results; Provides Commercial Update

May 11, 2023 6:50 AM EDT

-- First quarter 2023 UPNEEQ® net product sales grew 49%, or $2.9 million, over the prior year period to $8.8 million --

-- Enhanced operating leverage with a 32%, or $7.9 million, reduction in first quarter 2023 total operating expenditures from the prior year --

-- Majority of aesthetic orders in the first quarter, or 54%, represented reorder activity --

-- Approximately 4,800 cumulative unique medical aesthetics practices had placed orders for UPNEEQ through the end of the first quarter, a 12% increase from prior quarter end --

--... More